title: [Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø].
abstract: A pharmacoepidemiological survey was conducted in order to understand the pattern of migraine prophylactic drug utilization by French physicians. Neurologists and primary care physicians completed a phone-mail-phone questionnaire which inquired about migraine prophylactic treatment. French neurologists and PCP made the same use of migraine prophylaxis in terms of indication, time interval between treatment onset and evaluation, and duration. The two most commonly chosen migraine prophylactic agents were dihydroergotamine and beta-blockers. This study also showed the importance of considering quality of life to evaluate efficacy of migraine prophylaxis.
authors.affiliation: Département Douleur/Service de Neurologie, CHU de Nice.
authors.forename: M
authors.initials: M
authors.lastname: Lantéri-Minet
authors.forename: H
authors.initials: H
authors.lastname: Alchaar
authors.forename: G
authors.initials: G
authors.lastname: Besson
authors.forename: F
authors.initials: F
authors.lastname: Billé-Turc
authors.forename: J
authors.initials: J
authors.lastname: Bouillat
authors.forename: F
authors.initials: F
authors.lastname: Brudon
authors.forename: A
authors.initials: A
authors.lastname: Donnet
authors.forename: P
authors.initials: P
authors.lastname: Galletti
authors.forename: M
authors.initials: M
authors.lastname: Maitre
authors.forename: Y
authors.initials: Y
authors.lastname: Moene
authors.forename: G
authors.initials: G
authors.lastname: Rambaud
authors.forename: C
authors.initials: C
authors.lastname: Rostini
authors.forename: J
authors.initials: J
authors.lastname: Valance
authors.forename: J L
authors.initials: JL
authors.lastname: Gastaut
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004087:Dihydroergotamine / Q000627:therapeutic use*; D005194:Family Practice; D005602:France; D006801:Humans; D008881:Migraine Disorders / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D009462:Neurology; D010821:Physicians, Family; D011795:Surveys and Questionnaires; D013689:Telephone
chemical_list: D000319:Adrenergic beta-Antagonists; D004087:Dihydroergotamine